Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
Dr Mona Shahriari Discusses Treatment of Plaque Psoriasis in Patients With Skin of Color
October 26th 2023Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology, provides on overview of the treatment landscape in patients with skin of color with plaque psoriasis.
Read More
Dr April Armstrong: Clinician Education Needed to Overcome AD Treatment Barriers
October 26th 2023April Armstrong, MD, MPH, of University of California, Los Angeles, gave an overview of her Fall Clinical Dermatology session on treating atopic dermatitis (AD) in patients with diverse skin tones and weighed in on how to address related treatment barriers.
Read More
Sacubitril/Valsartan Reduces Natriuretic Peptide Levels, Improves QOL in Patients With HFpEF
October 26th 2023The improvement in quality of life (QOL) seen with use of sacubitril/valsartan for heart failure with preserved ejection fraction (HFpEF) could potentially result in more favorable clinical results.
Read More
GALACTIC Trial Reveals Less Successful RAAS Inhibitor Uptitration in Women Than Men
October 24th 2023Uptitration of renin-angiotensin-aldosterone system (RAAS) inhibitors was less successful in women than men with acute heart failure (AHF), especially in those with HF with reduced ejection fraction.
Read More
Dr April Armstrong Identifies Main AD Health Care Gaps
October 24th 2023April Armstrong, MD, MPH, of University of California, Los Angeles, explained that the main health care gap within the atopic dermatitis (AD) realm is that many clinicians are not comfortable prescribing systemic medications.
Read More
Darker Skin Means Different Presentations of Skin Diseases, Explains Dr James Song
October 23rd 2023Recognizing that skin diseases such as atopic dermatitis, psoriasis, and hidradenitis suppurativa present differently in skin of color can prevent delays in diagnosis and treatment, explained James Song, MD, director of clinical research and associate chief medical officer at Frontier Dermatology.
Read More
Dr James Q. Del Rosso Explores the Latest Advancements in Dermatology
October 22nd 2023There are many drugs that have been around for years and others with strong data awaiting FDA approval that are beneficial in treating conditions like atopic dermatitis and alopecia areata, said James Q. Del Rosso, DO.
Read More
Dr James Song Addresses Disparities in HS Presentation, Severity Among Diverse Patients
October 20th 2023Atopic dermatitis, psoriasis, and hidradenitis suppurativa (HS) can present differently in diverse patients, potentially leading to delayed diagnosis and therefore delayed treatment, explained James Song, MD, director of clinical research and associate chief medical officer at Frontier Dermatology.
Read More
Dr Raj Chovatiya Calls Ruxolitinib Cream a Game Changer for Nonsegmental Vitiligo
October 20th 2023The FDA approval of topical ruxolitinib 1.5% cream changed the game for vitiligo treatment in both adult and pediatric patients, said Raj Chovatiya, MD, PhD, assistant professor of dermatology at Northwestern University's Feinberg School of Medicine.
Read More
Dr Peter Lio: Setting a New Standard for Biologics Use in Atopic Dermatitis
October 20th 2023Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University's Feinberg School of Medicine, addresses how dermatologists need to focus on patient needs when determining the best use of new biologics in moderate to severe atopic dermatitis.
Read More
JAK Inhibitors Are Revolutionizing Dermatology Field, Says Dr Mona Shahriari
October 19th 2023Janus kinase (JAK) inhibitors are not only efficacious in terms of skin disease improvement, but also in terms of itch management, explained Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology.
Read More
What to Expect at Dr Peter Lio's AD Session: 2023 Fall Clinical Dermatology Conference
October 16th 2023Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine, gives a preview of his session on mild to moderate atopic dermatitis (AD) in skin of color.
Read More
Dr Javed Butler: How STEP-HFpEF Findings on Semaglutide Translate to Clinical Practice
October 13th 2023Positive results from STEP-HFpEF indicate that semaglutide can improve quality of life and functional capacity in patients with obesity-related heart failure with preserved ejection fraction (HFpEF), but large outcomes trials are needed to confirm this, said Javed Butler, MD, MPH, MBA.
Read More
Fabric Health: Breaking Down Barriers to Health Equity
October 12th 2023Fabric Health is transforming laundry time into an opportunity for community well-being, engaging families in laundromats to address health needs and connecting them with health care experts and needed social services. Adaptable and problem-solving oriented, the social-impact startup helps to bridge pandemic-exacerbated disparities by meeting people where they are, fostering health equity.
Read More
Dr Steven Deitelzweig: Identifying Patients With Atrial Fibrillation Using a Detection Device
October 10th 2023Steven Deitelzweig, MD, system chairman of hospital medicine at Ochsner Clinical School, professor of medicine at the University of Queensland, discusses key findings from a recent study on the accuracy of atrial fibrillation detection devices.
Read More